NCI Opens Search for Deputy Director to Guide Global Cancer Research
The National Cancer Institute is looking for a deputy director for its Center for Global Health, a role built around global oncology, research capacity building, and the translation of cancer science into programs that can work across health systems with very different resources. The position sits close to the center’s scientific and operational core: advising the director, setting priorities, and helping steer a portfolio that spans prevention, cancer control, implementation science, disparities research, training, and international collaboration.
The opening signals how much cancer control now depends on more than laboratory discovery. Drug development, screening strategies, treatment access, and workforce training all move differently when they are tested in countries with limited infrastructure, variable diagnostic capacity, or uneven access to oncology services. Leadership in this setting demands more than academic credentials; it requires fluency in policy, program design, and the practical limits of delivering cancer care across borders.
A Leadership Role Built Around Science, Policy, and Partnerships
The deputy director will serve as principal advisor to the center director on scientific, programmatic, operational, and policy matters. That combination matters because the job is not limited to managing an internal team. It extends into shaping how the institute allocates attention and resources across international cancer research, how it coordinates with other NIH components, and how it builds partnerships with ministries of health, academic institutions, multilateral organizations, and nongovernmental groups.
In practical terms, the role requires someone who can move from strategy to execution without losing sight of scientific rigor. A global cancer program can fail if it generates evidence that never reaches clinics, or if it funds capacity-building efforts that do not align with local disease burdens. The center’s priorities therefore appear to rest on the intersection of evidence generation and implementation, where research only has value if it changes diagnosis, treatment, prevention, or survivorship outcomes in the field.
The posting also places strong emphasis on multidisciplinary portfolios. Those include cancer prevention, cancer control, implementation science, global oncology, cancer disparities, and research training. Each of those domains reflects a different pressure point in the cancer burden worldwide. Prevention can reduce incidence before disease takes hold. Implementation science can reveal why proven interventions stall when they leave controlled settings. Research training and infrastructure building address the persistent shortage of local scientific leadership in many regions most affected by late diagnosis and limited treatment access.
Global Cancer Control Needs Infrastructure, Not Just Ideas
Cancer outcomes do not improve simply because a strategy works in one country. Screening tools, biomarkers, radiation access, pathology services, and treatment adherence all depend on systems that can support them. The deputy director will be expected to help develop and oversee initiatives that strengthen research infrastructure and international cancer research collaborations, which suggests a mandate that goes beyond grant making and into long-range institution building.
The qualifications reinforce that expectation. The position seeks an advanced doctoral degree in medicine, biomedical science, public health, epidemiology, global health, or a related field, along with senior-level experience in scientific research programs, research administration, or science policy. Experience translating evidence into research programs, policies, and funding strategies is also central. In this setting, evidence translation is not a vague ideal; it is the mechanism by which a trial result becomes a registry program, a prevention campaign, a training pipeline, or a bilateral research agreement.
A candidate would also need to have led complex multidisciplinary portfolios involving multiple organizations and stakeholders. That requirement reflects the reality of global cancer work, where no single institution controls every variable. Ministries of health shape national priorities. Academic collaborators supply local expertise and trainee pipelines. Federal agencies determine regulatory and funding constraints. International partners often bring technical support, data systems, or access to comparative cohorts. Coordinating those interests requires diplomatic skill as much as scientific judgment.
Senior Experience, Workforce Development, and Scientific Stewardship
The posting makes clear that the deputy director will manage scientific and administrative staff, financial resources, and program operations. This is a stewardship role as much as a scientific one. Accountability for public funds sits alongside the obligation to promote a collaborative and inclusive environment that supports innovation and professional development. In a federal research setting, that means the ability to keep portfolios organized, staff aligned, and priorities visible while avoiding fragmentation across too many competing projects.
Preferred qualifications point to national or international recognition in global oncology, cancer control, implementation science, or cancer disparities. Peer-reviewed publications, invited presentations, and leadership within the scientific community are all favored. The institute also wants someone who has worked across NIH institutes and centers and understands extramural and intramural research programs, grants administration, and federal research policy. Those requirements suggest a preference for a leader who can navigate both the scientific and bureaucratic sides of a large research enterprise.
The emphasis on inclusive culture and workforce development is not ornamental. Global cancer research depends on the training of investigators, data managers, clinicians, and implementation teams who can sustain programs after initial funding cycles end. When research capacity is weak, the resulting gaps show up quickly: delayed diagnosis, limited pathology confirmation, poor trial participation, and weak longitudinal follow-up. Building durable systems for training and collaboration is one way to reduce those failures.
Why the Position Matters for the Next Phase of Oncology Research
The posting arrives at a time when cancer is increasingly understood as a global systems problem, not only a biomedical one. Scientific advances in genomics, immunotherapy, and precision medicine can widen disparities if they remain inaccessible outside high-resource settings. A deputy director at the Center for Global Health would be positioned to help determine how NCI invests in that gap: which questions to prioritize, which partnerships to sustain, and how to make research usable in real-world settings.
Applications are open to U.S. citizens and non-citizens as allowed by appropriations and statute, with the position based in Bethesda, Maryland. The announcement asks for a CV, cover letter, bibliography of peer-reviewed publications if applicable, and professional references, with applications due by 11:59 p.m. ET on November 18, 2026. The final selection will likely hinge on whether a candidate can do something unusually difficult: align scientific ambition, policy discipline, and global health pragmatism inside one of the most influential cancer research institutions in the world.
The unanswered challenge is not whether global cancer collaboration is needed. The harder question is who can turn that need into research programs, partnerships, and infrastructure that endure long after a single appointment ends.